chr19-48968927-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_002103.5(GYS1):c.*361G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000261 in 509,676 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00071 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000070 ( 0 hom. )
Consequence
GYS1
NM_002103.5 3_prime_UTR
NM_002103.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0800
Genes affected
GYS1 (HGNC:4706): (glycogen synthase 1) The protein encoded by this gene catalyzes the addition of glucose monomers to the growing glycogen molecule through the formation of alpha-1,4-glycoside linkages. Mutations in this gene are associated with muscle glycogen storage disease. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 19-48968927-C-T is Benign according to our data. Variant chr19-48968927-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3357118.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000709 (108/152340) while in subpopulation AFR AF= 0.0025 (104/41578). AF 95% confidence interval is 0.00211. There are 0 homozygotes in gnomad4. There are 58 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GYS1 | NM_002103.5 | c.*361G>A | 3_prime_UTR_variant | 16/16 | ENST00000323798.8 | NP_002094.2 | ||
GYS1 | NM_001161587.2 | c.*361G>A | 3_prime_UTR_variant | 15/15 | NP_001155059.1 | |||
GYS1 | NR_027763.2 | n.2590G>A | non_coding_transcript_exon_variant | 15/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GYS1 | ENST00000323798 | c.*361G>A | 3_prime_UTR_variant | 16/16 | 1 | NM_002103.5 | ENSP00000317904.3 | |||
GYS1 | ENST00000263276 | c.*361G>A | 3_prime_UTR_variant | 15/15 | 1 | ENSP00000263276.6 |
Frequencies
GnomAD3 genomes AF: 0.000709 AC: 108AN: 152222Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
108
AN:
152222
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000119 AC: 16AN: 134922Hom.: 0 AF XY: 0.0000816 AC XY: 6AN XY: 73488
GnomAD3 exomes
AF:
AC:
16
AN:
134922
Hom.:
AF XY:
AC XY:
6
AN XY:
73488
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000700 AC: 25AN: 357336Hom.: 0 Cov.: 0 AF XY: 0.0000351 AC XY: 7AN XY: 199676
GnomAD4 exome
AF:
AC:
25
AN:
357336
Hom.:
Cov.:
0
AF XY:
AC XY:
7
AN XY:
199676
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000709 AC: 108AN: 152340Hom.: 0 Cov.: 32 AF XY: 0.000779 AC XY: 58AN XY: 74500
GnomAD4 genome
AF:
AC:
108
AN:
152340
Hom.:
Cov.:
32
AF XY:
AC XY:
58
AN XY:
74500
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
FTL-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 26, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at